Esperion Therapeutics
ESPR
#7606
Rank
C$0.42 B
Marketcap
$2.07
Share price
-4.00%
Change (1 day)
-45.07%
Change (1 year)

Esperion Therapeutics (ESPR) - Cash on Hand

Cash on Hand as of December 2024 : C$0.20 Billion

According to Esperion Therapeutics's latest financial reports the company has C$0.20 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Esperion Therapeutics - Cash on Hand chart (from 2000 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31C$0.20 B90.42%
2023-12-31C$0.10 B-51.82%
2022-12-31C$0.22 B-31.49%
2021-12-31C$0.33 B-15%
2020-12-31C$0.38 B48.28%
2019-12-31C$0.26 B41.52%
2018-12-31C$0.18 B-26.38%
2017-12-31C$0.25 B-11.48%
2016-12-31C$0.28 B-3.43%
2015-12-31C$0.29 B139.73%
2014-12-31C$0.12 B92.11%
2013-12-31C$63.93 M887.42%
2012-12-31C$6.47 M305.17%
2011-12-31C$1.59 M
2002-12-31C$70.84 M-36.73%
2001-12-31C$0.11 B6.42%
2000-12-31C$0.10 B1135.61%
1999-12-31C$8.51 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
C$0.87 B 321.40%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.63 B 685.92%๐Ÿ‡บ๐Ÿ‡ธ USA
C$29.46 B 14,045.38%๐Ÿ‡บ๐Ÿ‡ธ USA
C$12.96 B 6,125.78%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.35 B 72.66%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.34 B 64.38%๐Ÿ‡บ๐Ÿ‡ธ USA